Stockreport

Stemline Therapeutics misses by $0.20, revenue in-line [Seeking Alpha]

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
PDF Stemline Therapeutics (NASDAQ: STML ): Q1 EPS of -$0.67 . Revenue of $0.3M (+42.9% Y/Y) in-line. Press Release Now read: Albireo Pharma reports Q1 resu [Read more]